Evaluation of Prevent in Underserved Populations

NCT ID: NCT02664064

Last Updated: 2020-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

227 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to evaluate an online Diabetes Prevention Program adapted for patients with prediabetes in safety net health care settings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Diabetes Prevention Program (DPP) demonstrated that intensive behavioral counseling is a successful approach to reduce the risk of developing diabetes in patients with prediabetes. While the DPP lifestyle intervention was successful and group based adaptations of the DPP have positive results, scalable alternatives that allow for even broader reach are necessary. Omada Health has developed an online, group-based, recognized DPP program (Prevent). The goal of this study is to evaluate a literacy-adapted version of Prevent for patients with prediabetes in safety net health care settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prediabetes Overweight Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

online Diabetes Prevention Program

Participants will receive access to a 12-month online diabetes prevention program modeled after the CDC DPP curriculum. Participants receive online curriculum, access to a live health coach, interactive group message forums, and connected weight and activity monitoring devices.

Group Type EXPERIMENTAL

Prevent

Intervention Type BEHAVIORAL

Intensive behavioral counseling for diabetes prevention and healthy lifestyle management. Recipients have access to online curriculum, a live health coach, group-based communication forums, and connected technology to track weight and physical activity.

Matched Control

A de-identified dataset of control subjects matched on age, gender, prediabetes diagnosis, body mass index, comorbidities and socioeconomic status will be cultivated for comparison to the active intervention arm.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prevent

Intensive behavioral counseling for diabetes prevention and healthy lifestyle management. Recipients have access to online curriculum, a live health coach, group-based communication forums, and connected technology to track weight and physical activity.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* is receiving care at one of the three participating locations
* prediabetes diagnosis confirmed by lab tests
* age 18-75 at screening
* Not insured, Medicaid insured, or safety net health plan insured
* Comfortable speaking/reading English or Spanish at 5th grade level
* Body Mass Index greater or equal to 24
* Able to access the internet weekly by computer or smartphone
* Able to engage in physical activity of at least moderate intensity
* Able and willing to give informed consent to participate

Exclusion Criteria

* diagnosed with Type 1 or 2 Diabetes Mellitus
* taking insulin, metformin or other hypoglycemic agent
* pregnant or planning to become pregnant during trial period
* unstable life conditions that would preclude full program participation
* acute, unstable medical or mental health conditions that would preclude program participation
* inability to engage in physical activity of at least moderate intensity
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kresge Foundation

UNKNOWN

Sponsor Role collaborator

California HealthCare Foundation

OTHER

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role collaborator

Omada Health, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael R Cousineau, DrPh

Role: PRINCIPAL_INVESTIGATOR

University of Southern California

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LAC+USC Medical Center

Los Angeles, California, United States

Site Status

Northeast Valley Health Corporation

San Fernando, California, United States

Site Status

Providence Medical Group-Monroe Clinic

Monroe, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://omadahealth.com

Omada is a San Francisco-based healthcare technology company that is pioneering the field of digital behavioral medicine, to fulfill our mission of inspiring and enabling people everywhere to live free of chronic disease.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WIRB20152184

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diabetes Prevention Program
NCT00004992 COMPLETED PHASE3
Preventing Diabetes
NCT05395377 COMPLETED NA
Personalized Dietary Management in Type 2 Diabetes
NCT05046886 ACTIVE_NOT_RECRUITING NA
Diabetes Prevention for Black Men
NCT03708380 TERMINATED NA